---
title: "Exercise Timing and Cognition in Older Adults with Type 2 Diabetes and MCI: MRI RCT Protocol"
id: "plos-one-21-effects-and-mechanisms-of-exercise-timing-on-cognitive-function-in-older-type-2"
canonical_url: "https://medichelpline.com/clinical-feed/plos-one-21-effects-and-mechanisms-of-exercise-timing-on-cognitive-function-in-older-type-2"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "PLOS ONE (Medicine)"
source_url: "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361868"
published_at: "2026-11-04T14:00:00.000Z"
evidence_level: "Journal Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Exercise Timing and Cognition in Older Adults with Type 2 Diabetes and MCI: MRI RCT Protocol
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/plos-one-21-effects-and-mechanisms-of-exercise-timing-on-cognitive-function-in-older-type-2
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** PLOS ONE (Medicine)
- **Source URL:** [Original Journal Publication](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361868)
- **Published At:** 2026-11-04T14:00:00.000Z
- **Evidence Rating:** Journal Feed
## Executive GIST (TL;DR)
- This randomized, three-arm trial will compare **morning** versus **evening** home-based exercise against health education in older patients with **type 2 diabetes mellitus** and **mild cognitive impairment** (T2DM‑MCI). - Participants are aged 60–75, meet Petersen criteria for MCI, retain independent self-care, and report low physical activity; MRI contraindications do not exclude overall participation. - Intervention arms: 12 weeks, thrice-weekly sessions (5 min warm-up, 30 min aerobic, 30 min resistance, 5 min cool-down) delivered remotely at 09:00–10:10 (ME) or 19:00–20:10 (EE); intensity progressed across two stages. - Aerobic training uses music-guided calisthenics at 40–60% heart-rate reserve; resistance training uses elastic bands with 15RM then 12RM progression and standardized grip-width scaling. - Primary outcome is global cognition measured by the **Montreal Cognitive Assessment** (MoCA). Secondary outcomes include cognitive subdomain tests (N‑back, Stroop, ANT, Trail Making, Digit Symbol), multimodal **MRI** (T1, rs‑fMRI, DTI), glycemic indices, blood biomarkers, and physical fitness. - Randomization is 1:1:1 via block randomization (block size six) using an independent online system; blinding of participants and coaches is not feasible, but outcome assessors and analysts are blinded. - The team will assess mediation by glycemic control on cognitive and brain outcomes and will perform pre- and post-intervention testing within 48–72 hours of the final session. - As of August 18, 2026, 56 participants had been enrolled; trial registered at ChiCTR2300073737 and approved by Shanghai University of Sport ethics committee. - Safety monitoring includes continuous heart-rate tracking, RPE scoring, webcam supervision, session attendance logs, and stopping rules for adverse events; MRI scans will not be performed for participants with contraindications. - The protocol acknowledges limitations: participants/coaches unblinded, reliance on remote supervision, and absence of reported sample size calculation or power details in the source document.
## Clinical Analysis & Structured Key Points
Effects and mechanisms of exercise timing on cognitive function in older type 2 diabetes mellitus patients with mild cognitive impairment: A magnetic resonance imaging-based randomized controlled trial protocol | PLOS One Browse Subject Areas ? Click through the PLOS taxonomy to find articles in your field. For more information about PLOS Subject Areas, click here . Article Authors Metrics Comments Media Coverage Reader Comments Figures Figures Abstract Background Mild cognitive impairment (MCI) is a prevalent complication of type 2 diabetes mellitus (T2DM). Cognitive impairment progressively impairs self-care abilities, thereby triggering a vicious cycle of poor glycemic control and further cognitive decline. Exercise has been widely recognized as an effective strategy to improve both glycemic control and cognitive function; however, an optimal time of day for exercise to mitigate this neurodegenerative trajectory has not been determined. This trial aims to determine the most effective exercise timing to maximize cognitive benefits in older T2DM patients with MCI (T2DM-MCI) and to investigate the underlying neurobiological mechanisms using multimodal magnetic resonance imaging. Methods In this randomized controlled trial, patients 60–75 years of age with T2DM‐MCI will be assigned to a morning exercise group (09:00–10:10), an evening exercise group (19:00–20:10), or a health education group. The exercise groups will complete a 12-week, home-based, remotely supervised exercise program comprising aerobic and resistance exercises. The health education group will receive a 12-week health education program. Cognitive function will be evaluated at baseline and post-intervention using the Montreal Cognitive Assessment, Color-Word Stroop Test, N-back task, Trail making Test, Attention Network Test, and Digit Symbol Substitution Test. Additionally, brain structure and function based on imaging, blood biomarkers, and physical fitness will also be assessed. Discussion In this study, we aim to identify the optimal time of day for exercise to maximize cognitive benefits in patients with T2DM‐MCI and to elucidate underlying neurocognitive mechanisms. We will examine whether glycemic control mediates the relationship between exercise and cognitive function improvement. This research is expected to provide “time-specific” evidence for exercise prescription to maximize the neurocognitive benefits and mitigate dementia risk in this population. Trial registration Chinese Clinical Trial Registry: [ http://www.chictr.org.cn ], identifier [ChiCTR2300073737]. Citation: Lin Y, Ma Z, Zhang J, Zhuang J (2026) Effects and mechanisms of exercise timing on cognitive function in older type 2 diabetes mellitus patients with mild cognitive impairment: A magnetic resonance imaging-based randomized controlled trial protocol. PLoS One 21(11): e0361868. https://doi.org/10.1371/journal.pone.0361868 Editor: Sungho Maeng, Kyung Hee University, KOREA, REPUBLIC OF Received: February 24, 2026; Accepted: October 12, 2026; Published: November 4, 2026 Copyright: © 2026 Lin et al. This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Data Availability: No datasets were generated or analysed during the current study. Deidentified individual participant data will be deposited in a public repository (e.g., Zenodo) and made openly available once the trial has been completed, in compliance with applicable ethical and legal requirements. Funding: This study was funded by the Major Program of National Social Science Fund of China (No. 19ZDA352, http://www.nopss.gov.cn/GB/index.html) . JZ is the receivor of these award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing interests: The authors have declared that no competing interests exist. 1. Introduction Cognitive dysfunction is increasingly recognized as an age-dependent complication of type 2 diabetes mellitus (T2DM) [ 1 , 2 ]. The prevalence of mild cognitive impairment (MCI) is estimated to be 45.0% among individuals with T2DM [ 3 ]. T2DM-associated MCI profoundly impairs patients’ self-management abilities, potentially accelerating disease progression [ 4 , 5 ]. MCI represents a modifiable stage between normal cognitive aging and dementia [ 6 ], and good glycemic control may help reverse impairments [ 7 ]. Thus, this pre-dementia stage serves as a critical window for therapeutic intervention to improve cognitive function in patients with T2DM [ 8 ]. Human cognitive function is modulated by the circadian rhythm system, exhibiting specific diurnal variation [ 9 – 12 ]. Cognitive performance varies by the time of day [ 13 , 14 ]. Furthermore, circadian rhythms disruption, characterized by abnormal diurnal patterns and altered clock gene expression, has been observed in individuals with T2DM and Alzheimer’s disease [ 15 , 16 ]. The loss of circadian homeostasis exerts detrimental effects on overall health, including metabolic disturbances [ 17 ], accelerated cognitive decline, and brain atrophy [ 18 ]. A bidirectional relationship exists between circadian disruption and neurodegeneration, suggesting that circadian rhythms may play an important role in the progression of neurodegenerative diseases [ 15 , 18 , 19 ]. Exercise has been shown to improve cognitive function and reduce the severity of cognitive impairment in older T2DM patients with MCI (T2DM-MCI). Improved cognition may enhance self-management capability and treatment adherence, ultimately decelerating the progression of T2DM-related complications [ 20 – 23 ]. In addition, exercise serves as an important external cue for regulating the circadian rhythm system and act as a circadian synchronizer [ 24 ]. By improving circadian regulation, exercise promotes healthy aging and mitigate age-related physiological decline [ 25 – 27 ]. Researchers have proposed that the time of day for exercise should be aligned with circadian rhythms to maximize health benefits, implying the presence of an optimal exercise timing window [ 26 , 28 ]. Growing evidence indicates that the physiological benefits of exercise may depend on the time of day at which it is performed. A meta‑analysis involving adults across varying health conditions have shown that afternoon or evening exercise produces greater improvements in glucose control than morning exercise [ 29 ]. Importantly, exercise may improve cognitive function, at least in part, through glycemic modulation [ 30 – 32 ]. Therefore, identifying the optimal time of day for exercise to improve glycemic control is clinically relevant for older adults with T2DM-MCI. However, it remains unclear whether a specific time of day is most beneficial for exercise-induced cognitive improvement. Clarifying the optimal exercise timing for cognitive benefits is equally important and warrants rigorous investigation. Some studies have investigated the optimal time of day for exercise to improve cognitive function. Ingham-Hill et al. [ 33 ] and Khemila et al. [ 34 ] found that acute high-intensity exercise may be more effective in improving cognitive function in the morning than in the afternoon among adolescents. However, the results of Hasni et al. [ 35 ] and Maeneja et al. [ 36 ] did not support a significant time of day effect on the attention-related cognitive benefits of exercise. Overall, existing evidence on the optimal time of day for to confer cognitive benefits remains limited, with highly heterogeneous findings attributable to variations in study populations and exercise protocols. Additionally, there is a lack of studies examining long‑term cognitive adaptations to exercise performed at different times of day in adults with T2DM-MCI. Further research is needed to identify the optimal time of day for exercise and to explore the potential neural mechanisms using magnetic resonance imaging (MRI). Therefore, the primary objective of this study is to compare the effectiveness of morning versus evening exercise for improving cognitive function in older T2DM‐MCI patients. The secondary objectives are: (1) to determine whether morning exercise and evening exercise induce differential changes in brain structure and function, including brain volume, functional connectivity, and white matter integrity; and (2) to examine whether improved glycemic control mediate the effects of exercise intervention on cognitive function, brain structure and function. 2. Materials and methods 2.1 Overview of study design This is a three-arm, parallel-group, randomized controlled study that will be conducted at Shanghai University of Sport (Shanghai, China). Participants will be randomly assigned to one of three groups: morning exercise (ME), evening exercise (EE) or health education (HE). Participants in the exercise groups will receive a 12-week supervised training program combining aerobic and resistance exercise either from 09:00–10:10 (ME group) or 19:00–20:10 (EE group). The HE group will attend a health education course. All participants will be instructed to maintain their usual daily routine throughout the study period. Outcome assessments will be conducted at three timepoints: pre-intervention (week 0) and post-intervention (week 12). Fig 1 shows a detailed schedule of the participant enrolment, intervention, and assessments. And Fig 2 shows the study flowchart. Download: PNG larger image TIFF original image Fig 1. Participants timeline schematic. Abbreviations: MoCA, Montreal Cognitive Assessment; MMSE, Mini-Mental State Examination; IADL, Instrumental Activities of Daily Living; HAMD, Hamilton Depression Rating Scale; IPAQ, International Physical Activity Questionnaire; MRI: magnetic resonance imaging. https://doi.org/10.1371/journal.pone.0361868.g001 Download: PNG larger image TIFF original image Fig 2. Flowchart of participants during the trial. Abbreviations: ME: morning exercise; EE: evening exercise; HE: health education. https://doi.org/10.1371/journal.pone.0361868.g002 Study hypotheses. Hypothesis 1: Evening exercise will yield greater improvements in cognitive function, brain function, brain structure, and glycemic control than morning exercise. Hypothesis 2: Glycemic control will mediate the beneficial effects of exercise on cognitive function and brain health. 2.2 Participants The participants will be recruited from local hospitals and communities in Shanghai, China, via posters, health lectures, and word-of-mouth communication among researchers. Recruitment taking place from August 15, 2024, to October 30, 2026. Physicians will screen potential participants using the eligibility criteria, provide a brief introduction to the study, and refer eligible participants to the research team. The researchers will then provide detailed information about the study, confirm each individual’s willingness to participate, and obtain written informed consent. Our study was approved by the ethics committee of Shanghai University of Sport (number: 102772022RT078, date: 15 May 2023) and registered in the Chinese Clinical Trial Registry (number: ChiCTR2300073737, date: 19 July 2023). The study will be conducted in accordance with the Declaration of Helsinki. As of August 18, 2026, a total of 56 participants had been enrolled. The eligibility criteria are as follows: (1) 60–75 years of age; (2) clinical diagnosis of T2DM and meeting Peterson’s criteria for MCI [ 37 ], including a subjective memory complaint, Montreal Cognitive Assessment (MoCA) score 7; (5) alcohol abuse; (6) dyskinesia; and (7) fewer than 6 years of education. Participants with contraindications to MRI will not be excluded from the overall study; however, MRI scanning will not be performed in these individuals. Participation will be discontinued if any of the following occur: (1) voluntary withdrawal; (2) severe adverse events during the exercise intervention period, such as fractures and major cardiovascular events; or (3) the development of incidental clinical conditions, such as cancer and stroke, that may interfere with the assessment of outcomes. 2.3 Randomization and masking Following baseline assessments, the eligible participants will be randomly allocated to ME, EE, and HE groups in a 1:1:1 ratio using block randomization with a block size of six. The randomization sequence will be generated by an independent statistician and implemented through an independent online computerized randomization system ( https://www.sealedenvelope.com/simple-randomiser/v1/lists ). Owing to the nature of the exercise intervention, masking of participants and fitness coaches is not feasible; however, outcome assessors and data analysis will remain blinded to group allocation. In addition, fitness coaches involved in the intervention will be separated from the outcome assessors to ensure the integrity of the blinding process. The study will be unblinded only after the completion of the statistical analysis. 2.4 Intervention Participants in the ME and EE groups will complete home-based exercise through the Tencent Meeting platform, which will be used to stream the exercise intervention videos in real time. All exercise sessions will be performed in the post‑prandial state. Considering that the participants are physically inactive older adults, the entire exercise intervention will be divided into two phases: Stage 1, an exercise‑adaptation phase, and Stage 2, a maintenance phase. As shown in Table 1 , the 12-week intervention will comprise three non-consecutive sessions per week. Each session will comprise 5 minutes of warm-up, 30 minutes of aerobic exercise, 30 minutes of resistance exercise, and 5 minutes of cool-down. Download: PNG larger image TIFF original image Table 1. Multicomponent exercise protocol. https://doi.org/10.1371/journal.pone.0361868.t001 The aerobic exercise will consist of music-guided calisthenics performed at 40–60% heart rate reserve (HRR). Aerobic exercise intensity will be set at 40–50% heart rate reserve (HRR) in Stage 1, and increased to 50–60% HRR in Stage 2. This protocol has been from Watanabe et al. [ 38 ], with video playback speed adjusted monthly to maintain the target intensity. The resistance exercise will involve full-body training using elastic bands. Each resistance exercise session will be performed for two sets of 15 repetitions maximum (RM) in Stage 1 and 12 RM in Stage 2, with 15-second rest intervals between exercises and 2-minutes rest intervals between the two sets. The resistance exercise will comprise 10 exercises: reverse fly (pull apart), chest press, front raise, bicep curl, lateral trunk flexion, leg press, hip abduction, standing calf raise, squat, and lateral walk. The fitness coach will determine the initial resistance level of the bands according to each participant’s upper- and lower- limb functional capacity and will make monthly adjustments as needed. The procedures used to assess 15RM and 12RM in the present study will be adapted to Pan Z et al. [ 39 ]. Each elastic resistance band will be pre‑marked with 16 segments spaced at 10‑cm intervals. The midpoint of the band will be set as zero, with numbers 1–8 marked symmetrically on either side to form a standardized grip‑width scale. A narrower grip width will produce higher resistance. Participants will be instructed to adjust the grip width based on their strength capacity to determine the grip position corresponding to their 15RM or 12RM. The target grip width will be confirmed when participants reach volitional fatigue or muscular failure after completing 15 or 12 repetitions, respectively. Before the intervention begins, the fitness coach will conduct a face-to-face training session to confirm that the participants have the ability to perform the exercises correctly and safely. A WeChat group will be established to facilitate communication and to provide intervention-related reminders and guidance. Five minutes before each exercise session, the fitness coach will send a reminder message to prompt participants to join the Tencent Meeting online room on time. During each session, the participants will be required to keep their web cameras on to enable real-time supervision and guidance. The heart rates will be continuously monitored using a Polar® Vantage V Titan (Polar Electro Oy, Kempele, Finland). After each session, the exercise intensity will be assessed using the Borg Scales for rating of perceived exertion (ranges from 6–20; 6 represents no exertion and 20 indicates maximal exertion) [ 40 ]. Attendance will be recorded at each session. If a participant experiences any adverse symptoms (e.g., injury, palpitations, hypoglycemia, pain, or dyspnea), the exercise session will be stopped immediately. The HE group will receive a 30-minute health education course once per week for 12 weeks. Topics will include medication use, glucose monitoring, interpretation of key clinical indicators of T2DM, and recognizing signs of poor glycemic control. 2.5 Measurements Demographic characteristics, medical history, medication use, anthropometric data (e.g., height, weight, waist circumference, and body composition), daily physical activity levels will be collected at baseline. The outcome measures will be assessed at pre- and post-intervention. Post-intervention assessments will be performed within 48–72 hours after the final exercise session. A standardized assessment procedure will be implemented in this study. Each measurement (cognitive assessments, MRI scanning, blood sampling and physical fitness tests) will be completed within its fixed assessment window in the morning. Cognitive function will be evaluated based on a battery of neuropsychological tests. Magnetic resonance imaging (MRI) scans will include T1‑weighted imaging, resting‑state functional MRI (rs‑fMRI), and diffusion tensor imaging (DTI). A consecutive 3-day food diary will be recorded before each assessment visit. An oral glucose tolerance test and physical fitness assessments will also be conducted. In addition, we will record the class, dose, and administration timing of all medications at each assessment time‑point. 2.5.1 The primary outcome. Global Cognitive Function: Global cognitive function will be measured using the MoCA, which is widely used internationally and has been validated in older adults [ 41 , 42 ]. MoCA scores range from 0 to 30, with higher scores indicating better global cognitive performance. 2.5.2 The secondary outcomes. Cognitive Subdomains Assessments: Cognitive subdomains will be assessed using a battery of neuropsychological tests, including N-back task, Color-Word Stroop Test, Attention Network Test (ANT), Trail Making Test (Parts A and B), and Digit Symbol Substitution Test. Working memory will be assessed using the N-back task [ 43 , 44 ]. During the task, participants will view single digits (0–9, white font on a black background) presented in pseudorandom order. A total of nine blocks will be presented: three 0-Back, three 1-Back, and
## Related Clinical Research

- [Insomnia linked to higher risk of stroke and hospital admission, major review finds](https://medichelpline.com/clinical-feed/medical-news-today-0-major-review-links-insomnia-to-increased-risk-of-hospitalization-and-stroke.md)
- [2026 Stroke Rehabilitation Guideline: Start Early and Address Physical, Cognitive, and Mental Heal](https://medichelpline.com/clinical-feed/medical-news-today-0-stroke-rehab-guidelines-emphasize-early-support-for-physical-cognitive-and.md)
- [Exercise Prescriptions for Concussion Recovery: An Urgent Call to Action](https://medichelpline.com/clinical-feed/stat-news-2-opinion-more-doctors-should-prescribe-exercise-after-a-concussion.md)
- [Capsida follow-up: investigators report progress after death in gene therapy trial](https://medichelpline.com/clinical-feed/stat-news-0-stat-after-death-in-gene-therapy-trial-for-a-brain-disease-progress-is-reported.md)
- [Polygenic Pathways to Dementia: Premorbid Cognitive Level Versus Aging-Related Decline](https://medichelpline.com/clinical-feed/medrxiv-5-joint-longitudinal-hazard-modeling-distinguishes-polygenic-effects-on-dementia.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.